Latest Headlines

Latest Headlines

ASCO: Provista's autoantibody/biomarker combo boosts breast cancer screening accuracy

Provista Diagnostics is celebrating some early clinical data that support its approach of using autoantibodies and serum protein biomarkers together to help differentiate between invasive breast cancer and benign breast conditions.

Quest scientists and others identify new rheumatoid arthritis biomarker

Researchers have identified a new biomarker for rheumatoid arthritis that could help with earlier diagnosis and treatment.

MIT discovers malaria parasitic waste has Dx biomarker potential

Malaria parasites produce waste products as they spread in the blood. Those parasitic discharges may give scientists an ideal diagnostic biomarker to help spot the infection and determine how serious it is, researchers have found.

Tuberculosis biomarker predicts protection against disease symptoms

Scientists have pinpointed a protein that plays a role in protection against  Mycobacterium tuberculosis  in people who are infected with the pathogen. 

UCLA, Harvard and others identify possible TB biomarker

There's a new biomarker in the mix that could help diagnose patients at high risk for tuberculosis and lead to targeted treatments to combat it.

FDA signs off on highly specific Type 1 diabetes biomarker test

The FDA has signed off on a new, highly specific biomarker blood test designed by an Idaho company to quickly spot Type 1 diabetes.

Flagship Biosciences and Sarepta will automate muscular dystrophy biomarker detection

Tissue-based companion diagnostics company Flagship Biosciences said it will join with Sarepta Therapeutics to automate and quicken measurement of a key biomarker for muscular dystrophy.

Protagen rolls out autoimmune disease test for research use

Germany's Protagen said it is rolling out its first diagnostic test kit for systemic sclerosis, a rheumatic disease in which autoimmune-induced inflammation, fibrosis and blood vessel disorders can harm a patient's organs and eventually cause death.

GE Healthcare vet to take on Biocept's Dx reimbursement strategy

Biocept is bringing on a veteran GE Healthcare and Quest Diagnostics executive to guide the company's insurance reimbursement and medical contract strategy.

Northern Ireland outfit advances a rapid but inexpensive heart attack test

A company based in Northern Ireland is advancing a rapid blood test to screen for a heart attack, allowing for doctors to more quickly treat affected patients. Randox Health's low-cost diagnostic has shown promise in early testing.